17beta-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy.
暂无分享,去创建一个
[1] C. Hinojosa-Laborde,et al. Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat. , 2004, Journal of the American Society of Nephrology : JASN.
[2] E. Barrett-Connor,et al. Women and heart disease: the role of diabetes and hyperglycemia. , 2004, Archives of internal medicine.
[3] M. Cooper,et al. Use of genetic mouse models in the study of diabetic nephropathy , 2004, Current diabetes reports.
[4] John Robbins,et al. National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section , 2004, BMJ : British Medical Journal.
[5] C. Torp‐Pedersen,et al. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. , 2004, Journal of the American College of Cardiology.
[6] Richard J. Johnson,et al. The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. , 2004, The American journal of pathology.
[7] E. Ritz,et al. Beneficial Effects of Estrogens on Indices of Renal Damage in Uninephrectomized SHRsp Rats. , 2004, Journal of the American Society of Nephrology : JASN.
[8] F. Ziyadeh,et al. Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. , 2003, Seminars in nephrology.
[9] M. Koulu,et al. Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion. , 2003, American journal of physiology. Endocrinology and metabolism.
[10] D. Mikhailidis,et al. The Effects of Transdermal Estradiol Alone or with Cyclical Dydrogesterone on Markers of Cardiovascular Disease Risk in Postmenopausal Women with Type 2 Diabetes: A Pilot Study , 2003, Angiology.
[11] L. Gesualdo,et al. Clinical and therapeutic aspects of diabetic nephropathy. , 2003, Journal of nephrology.
[12] G. Striker,et al. Estrogen deficiency accelerates progression of glomerulosclerosis in susceptible mice. , 2003, The American journal of pathology.
[13] S. Silbiger,et al. Estradiol reverses TGF-beta1-induced mesangial cell apoptosis by a casein kinase 2-dependent mechanism. , 2002, Kidney international.
[14] S. Aoki,et al. Different Effects of Castration and Estrogen Administration on Glomerular Injury in Spontaneously Hyperglycemic Otsuka Long-Evans Tokushima Fatty (OLETF) Rats , 2002, Nephron.
[15] B. Howard,et al. The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in american Indian postmenopausal women : the strong heart study. , 2002, Diabetes care.
[16] S. Oparil,et al. Sex hormones and hypertension. , 2002, Cardiovascular research.
[17] L. Zacharia,et al. Role of Methoxyestradiols in the Growth Inhibitory Effects of Estradiol on Human Glomerular Mesangial Cells , 2002, Hypertension.
[18] B V Howard,et al. Diabetes and cardiovascular disease. , 2002, Annual review of medicine.
[19] Tetsuya Yamamoto,et al. Cross-talk between Transforming Growth Factor-β and Estrogen Receptor Signaling through Smad3* , 2001, The Journal of Biological Chemistry.
[20] A. Thorburn,et al. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y , 2001, International Journal of Obesity.
[21] G. Striker,et al. Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. , 2001, Journal of the American Society of Nephrology : JASN.
[22] S. Silbiger,et al. Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. , 2000, American journal of physiology. Renal physiology.
[23] Z. Vajo,et al. Postmenopausal hormone replacement improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension , 2000, BJOG : an international journal of obstetrics and gynaecology.
[24] S. Silbiger,et al. Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade. , 1999, American journal of physiology. Renal physiology.
[25] M. Cooper,et al. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? , 1999, Kidney international.
[26] G. Wolf,et al. Molecular mechanisms of diabetic renal hypertrophy. , 1999, Kidney international.
[27] H. Parving,et al. Progression of diabetic nephropathy in normotensive type 1 diabetic patients. , 1999, Kidney international. Supplement.
[28] S. Silbiger,et al. Estradiol suppresses type I collagen synthesis in mesangial cells via activation of activator protein-1. , 1999, Kidney international.
[29] J. Sowers,et al. Diabetes and cardiovascular disease. , 1999, Diabetes care.
[30] K. Flegal,et al. Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.
[31] G. Remuzzi,et al. Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes , 1998, BMJ.
[32] E. Barrett-Connor,et al. The effect of postmenopausal estrogen therapy on the risk of non-insulin-dependent diabetes mellitus. , 1997, American journal of public health.
[33] V. Fidler,et al. Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation. Evidence for involvement of macrophages and lipids. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[34] D. DuBois,et al. A formula to estimate the approximate surface area if height and weight be known , 1989 .
[35] R. Atkins,et al. The enhancement of aminonucleoside nephrosis by the co-administration of protamine. , 1987, Kidney international.
[36] E. Rosenmann,et al. Effect of the Estrogen Antagonist, Tamoxifen, on Development of Glomerulosclerosis in the Cohen Diabetic Rat , 1985, Diabetes.
[37] L. Yanko,et al. Female Sex Hormone and Nephropathy in Cohen Diabetic Rat (Genetically Selected Sucrose-Fed) , 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[38] D. D. Bois,et al. CLINICAL CALORIMETRY: TENTH PAPER A FORMULA TO ESTIMATE THE APPROXIMATE SURFACE AREA IF HEIGHT AND WEIGHT BE KNOWN , 1916 .
[39] John M. Lachin,et al. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. , 2003, JAMA.
[40] Z. Nemes,et al. Estradiol is nephroprotective in the rat remnant kidney. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[41] S. Goldfarb,et al. TGF-beta: a crucial component of the pathogenesis of diabetic nephropathy. , 2001, Transactions of the American Clinical and Climatological Association.
[42] J. Pugh,et al. Predictors of the rate of renal function decline in non-insulin-dependent diabetes mellitus. , 1997, American journal of nephrology.
[43] J. D. Neill,et al. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. , 1975, Endocrinology.